{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:00:36Z","timestamp":1769018436553,"version":"3.49.0"},"reference-count":123,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RC-2024-2790092"],"award-info":[{"award-number":["RC-2024-2790092"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.1080\/14712598.2024.2433518","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T10:57:43Z","timestamp":1733741863000},"page":"27-46","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma"],"prefix":"10.1080","volume":"25","author":[{"given":"Katia","family":"Mancuso","sequence":"first","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Barbato","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Talarico","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Tacchetti","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Zamagni","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Cavo","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Mediche e Chirurgiche, Universit\u00e0 di Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051558"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01531-2"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.138"},{"key":"e_1_3_5_6_1","unstructured":"U.S. Food & Drugs Administration. FDA approves first cell-based gene therapy for adult patients with multiple myeloma. 2021 Mar 27. Available from: https:\/\/www.fda.gov"},{"key":"e_1_3_5_7_1","unstructured":"Bristol Myers Squibb. Bristol myers squibb receives European Commission approval for Abecma (idecabtagene vicleucel) the first anti-bcma CAR T cell therapy for relapsed and refractory multiple myeloma. Published August 19 2021. Accessed August 20 2021. https:\/\/news.bms.com\/news\/details\/2021\/Bristol-Myers-Squibb-Receives-European-Commission-Approval-for-Abecma-Idecabtagene-Vicleucel-the-First-Anti-BCMA-CAR-T-Cell-Therapy-for-Relapsed-and-Refractory-Multiple-Myeloma\/default.aspx"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-010-0028-z"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09241.x"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-691162"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2224"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2043"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1984"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00043-14"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01262.x"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0734-z"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2133540"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/cimb44040098"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14145"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2018-0199"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184088"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812223192527"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature22395"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.001"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0437-8"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.07.013"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102931"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10824-3"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024850"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01049-z"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134324"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02496-0"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-116953"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146518"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.8016"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213614"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174477"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)01658-0"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)01649-X"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)01626-9"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174477"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00080-2"},{"key":"e_1_3_5_45_1","unstructured":"U.S. FDA approves Bristol Myers Squibb and 2seventy bio\u2019s Abecma for triple-class exposed relapsed or refractory multiple myeloma after two prior lines of therapy. News release. Bristol Myers Squibb. 2024 Apr 5 [cited 2024 Apr 5]. Available from: https:\/\/tinyurl.com\/fxrxybvm"},{"key":"e_1_3_5_46_1","unstructured":"Bristol Myers Squibb\u2019s Abecma (idecabtagene vicleucel) becomes first CAR T cell therapy approved in the European Union in earlier lines for triple-class exposed relapsed and refractory multiple myeloma. News release. Bristol Myers Squibb. 2024 Mar 20 [cited 2024 Mar 21]. Available from: https:\/\/tinyurl.com\/4cmdxxkt"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-631200"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-162469"},{"key":"e_1_3_5_49_1","volume-title":"Presented at the 2024 European Hematology Association (EHA) Congress","author":"Leleu X","unstructured":"Leleu X, Chung A, Raje N, et al. Idecabtagene vicleucel in patients with clinical high-risk early relapse multiple myeloma without front-line autologous stem cell transplantation: KarMMa-2 cohort 2b. In: Presented at the 2024 European Hematology Association (EHA) Congress; Madrid, Spain; 2024 Jun 13\u201316. S208. (Abstract release date: 05\/14\/24) EHA Library. Leleu X. 06\/13\/2024; 422312; S208."},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173970"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00507-2"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.01365"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181762"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19505"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19302"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00886-8"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02132-2"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282510"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01555-4"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-170119"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-167804"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31430-0"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02206-w"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(24)00094-9"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8002"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283940"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009766"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008320"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139009"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147412"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-23-0044"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303379"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35107"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7540"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02528-9"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204591"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)01689-6"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8036"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.03.012"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134322"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.02232"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01465-x"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-00993-0"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00159-6"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146060"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17527"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010653"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02404-6"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00629-1"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024582"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017414"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.04.001"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020578"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000472"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1855143"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004079"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01521-5"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021221"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126397"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.276402"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01245-5"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21177-5"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004418"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02491-5"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000050"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281339"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781351"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-24-0017"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8005"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.568056"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.479"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12254"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1101495"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209900"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39395-4"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-778423"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02959-8"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024166"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005913"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194711"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179152"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/BS9.0000000000000184"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-22-0074"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181573"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00842"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2024.2433518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:02:20Z","timestamp":1735776140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2024.2433518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"alternative-id":["10.1080\/14712598.2024.2433518"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2024.2433518","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}